Latest News for: dsmb

Edit

BriaCell Receives Positive Recommendation from Data Safety Monitoring Board (DSMB) for Phase 3 Study in ...

Nasdaq Globe Newswire 17 Feb 2026
BCT) (“BriaCell” or the “Company”), clinical-stage biotechnology company developing novel immunotherapies to transform ...
Edit

Diakonos Oncology Announces Study to Continue after First DSMB Safety Review of DOC1021 in Phase 2 GBM Study

PR Newswire 17 Feb 2026
The DSMB's recommendation followed a review of available safety data from patients randomized in the DOC-GBM2 study.
Edit

Annovis Secures DSMB Approval to Advance Pivotal Phase 3 Trial of Buntanetap in Alzheimer’s Disease

Nasdaq Globe Newswire 12 Feb 2026
ANVS) (“Annovis” or the “Company”), a Phase 3 clinical-stage biotechnology company developing the investigational ...
Edit

Annovis Secures DSMB Approval to Advance Pivotal Phase 3 Trial of Buntanetap in Alzheimer’s Disease (Form 8-K) (Annovis Bio Inc)

Public Technologies 12 Feb 2026
Annovis Secures DSMB Approval to Advance Pivotal Phase 3 Trial of Buntanetap in Alzheimer's Disease ... "We are pleased to receive this positive recommendation from the DSMB," said Maria Maccecchini, Ph.D., President, and CEO of Annovis.
Edit

Foresee Pharmaceuticals Receives the Fourth Positive Recommendation from the DSMB to Continue the Casppian Ph3 Study, for Central Precocious Puberty (CPP)

PR Newswire 04 Feb 2026
The independent Data and Safety Monitoring Board (DSMB) recommended the continuation of the study as planned ... "With this critical DSMB affirmation, we are charging ahead in our mission to add to the existing therapies of care for children with CPP.
Edit

Estrella Advances STARLIGHT-1 Trial into Phase II Following Positive DSMB Recommendation (Form 8-K) (Estrella Immunopharma Inc)

Public Technologies 04 Dec 2025
Estrella Advances STARLIGHT-1 Trial into Phase II Following Positive DSMB Recommendation ● An ... ● DSMB recommends advancement of STARLIGHT-1 to Phase II at the Recommended Phase II Dose (RP2D).
  • 1
×